Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novavax Inc (NASDAQ:NVAX)

1.33
Delayed Data
As of 3:59pm ET
 -0.13 / -8.90%
Today’s Change
1.16
Today|||52-Week Range
8.95
-84.15%
Year-to-Date
Why Novavax Stock Crashed in November
Dec 06 / MotleyFool.com - Paid Partner Content
The Worst Biotech Stocks of 2016
Dec 02 / MotleyFool.com - Paid Partner Content
Read This Before You Buy Biotech Stocks
Dec 05 / MotleyFool.com - Paid Partner Content
3 Drug Stocks Investors Shouldn't Touch With a 10-Foot Pole in 2017
Dec 01 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close1.46
Today’s open1.48
Day’s range1.33 - 1.49
Volume10,526,178
Average volume (3 months)15,548,311
Market cap$396.0M
Dividend yield--
Data as of 3:59pm ET, 12/07/2016

Growth & Valuation

Earnings growth (last year)-62.16%
Earnings growth (this year)-75.05%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+18.24%
P/E ratioNM
Price/Sales60.70
Price/Book1.35

Competitors

 Today’s
change
Today’s
% change
SYRSSyros Pharmaceutical...-0.03-0.18%
AGENAgenus Inc-0.25-5.75%
NDRMNeuroderm Ltd-0.40-2.09%
BCRXBioCryst Pharmaceuti...-0.13-2.30%
Data as of 3:59pm ET, 12/07/2016

Financials

Next reporting dateMarch 13, 2017
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$36.3M
Annual profit (last year)-$156.9M
Net profit margin-432.93%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Senior Vice President-
Quality Operations
Robert Darius
Corporate headquarters
Gaithersburg, Maryland

Forecasts


Search for Jobs